With a new organizational structure meant to accelerate growth, Imperative Care is seeking to improve care even more for people with strokes and other ischemic diseases. There is an urgent need for better stroke care. Strokes hit a new person every 40 seconds in the U.S. — and kill someone about every 3 minutes, according […]
DeviceTalks West
What’s next for Abbott’s cardiovascular business?
Abbott boosted its vascular device offerings even more with its acquisition of Cardiovascular Systems this year. Wondering what comes next? Abbott Vascular President Julie Tyler will explain at our DeviceTalks West event, Oct. 18–19 in Santa Clara. (Register here.) Even as COVID-19 test sales continue to decline and hammer overall revenue, Abbott officials are betting […]
How Intuitive plans to continue its surgical robotics leadership
Companies large and small have sought to take on Intuitive in soft-tissue surgical robotics, but it has maintained its dominance. Intuitive President Dave Rosa will explain how Intuitive plans to continue maintaining distance from its competitors — and much more, during DeviceTalks West next week. Register here for the event, which is Oct. 18–19 in […]
Imperative Care reports positive data for stroke treatment following expanded FDA nod
Imperative Care today announced positive data from a neurovascular outcome database evaluating its Zoom stroke solution. The announcement for the study results comes just a week after the FDA cleared an expansion to the Zoom portfolio. Imperative Care will discuss its Zoom platform and its efforts to build next-generation devices at DeviceTalks West in October. Check out […]
How Johnson & Johnson is looking to lead the way in ablation
Celine Martin, Johnson & Johnson group chair, cardiovascular & specialty solutions (CSS) group, oversees high-growth areas at the company’s global MedTech business. Her leadership covers Acclarent, Biosense Webster, Cerenovus and Mentor. Together, those companies bring in more than $5 billion in annual sales with more than 14,000 employees. Over 25 years at Johnson & Johnson, […]
Medtronic unveils new neurovascular innovation incubator program
Medtronic (NYSE:MDT) revealed its plans for an incubation and acceleration platform for innovation in the neurovascular space. In a presentation yesterday at DeviceTalks West in Santa Clara, California, the company unveiled its plan to bring innovations to market to address strokes. Daniel Volz, president of Medtronic Neurovascular, and Derek Crittenden, Medtronic’s new technology & strategy […]
Ablation is the next step for Intuitive’s Ion system
Intuitive is best known for its da Vinci surgical robotics system, but there is buzz around its Ion system with its fully articulating catheter making its way through the lungs for cancer biopsy. Watch out for the Ion doing even more down the road. CEO Gary Guthart announced during Intuitive’s Q3 earnings call yesterday evening […]
What’s next for the medical device supply chain?
Recent hurricanes in Florida and Puerto Rico provide yet another reminder that the medical device supply chain remains vulnerable to climate change. The COVID-19 pandemic presented its challenges. But as our sister Medical Design & Outsourcing site reported last year, expect superstorms, fires, droughts and other extreme events driven by climate change to continue to […]
DeviceTalks West 2019: Medtech expertise you need to know
There was a wide variety of expertise to be had on the show floor of DeviceTalks West, held in December 2019 in Silicon Valley. Find out about materials testing standards from Eurofins, the evolving nature of contract manufacturing at Tegra Medical, improved medical device design strategies from Triple Ring Technologies, big-box builds at Valtronic, and […]
4 medical device industry trends affecting innovation
Major medical device companies are increasingly outsourcing their innovation. Here’s what that means. The medical device industry is increasingly relying on small, young companies to provide innovations, but the early-stage medtech companies are mostly relying on angel investors. It’s also more important than ever to protect intellectual property and mitigate exposure to litigation. Those were […]
Experts explore the state of M&A in medtech
At DeviceTalks West 2018, a panel of experts gathered to discuss the state of M&A in medtech and the forces driving startups to seek an exit. Buyouts like Medtronic‘s (NYSE:MDT) $1.7 billion acquisition of Mazor Robotics (NSDQ:MZOR) dominated the headlines in 2018, but industry veteran Shayan Bhattacharyya found himself intrigued by the smaller deals that didn’t […]
